Re: Cost-Effectiveness Analysis of Sacral Neuromodulation and Botulinum Toxin A Treatment for Patients With Idiopathic Overactive Bladder Editorial Comment

被引：0
|
作者：
Penson, David F.
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 06期
关键词：
D O I：
10.1016/j.juro.2012.02.2534
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2157 / 2158
页数：3
相关论文
共 50 条
  • [21] Cost Effectiveness of Sacral Neuromodulation and OnabotulinumtoxinA in Managing Refractory Idiopathic Overactive Bladder
    Tay, Li June
    Harry, Deepak
    Malde, Sachin
    Sahai, Arun
    UROLOGY, 2021, 149 : 1 - 10
  • [22] THE COST-UTILITY OF SACRAL NEUROMODULATION VERSUS BOTULINUM TOXIN A FOR THE TREATMENT OF REFRACTORY IDIOPATHIC OVERACTIVE BLADDER (WITH URGENCY URINARY INCONTINENCE) IN SWEDEN
    Borisenko, O.
    Reimer, E.
    Colpan, Z.
    Petkovski, A.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S239 - S240
  • [23] SACRAL NERVE STIMULATION AND BOTULINUM TOXIN A FOR THE TREATMENT OF REFRACTORY IDIOPATHIC OVERACTIVE BLADDER: AN INDEPENDENT COST-EFFECTIVENESS ANALYSIS IN THE PERSPECTIVE OF ITALIAN NATIONAL HEALTH CARE SERVICE
    Bertapelle, M. P.
    D'Ausilio, A.
    Vottero, M.
    Del Popolo, G.
    Giannantoni, A.
    Mencarini, M.
    Ostardo, E.
    Spinelli, M.
    NEUROUROLOGY AND URODYNAMICS, 2013, 32 (06) : 688 - 688
  • [24] Cost-Effectiveness of Sacral Neuromodulation Versus Intravesical Botulinum A Toxin for Treatment of Refractory Urge Incontinence
    Siddiqui, Nazema Y.
    Amundsen, Cindy L.
    Visco, Anthony G.
    Myers, Evan R.
    Wu, Jennifer M.
    JOURNAL OF UROLOGY, 2009, 182 (06): : 2799 - 2804
  • [25] Cost-Effectiveness Analysis Between Sacral Neuromodulation and OnabotulinumtoxinA for the Treatment of Refractory Overactive Bladder in Women: A Systematic Review
    Gerjevic, Kristen A.
    Ahmad, Sophia
    Strohbehn, Kris
    Riblet, Natalie
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2021, 27 (08): : 481 - 487
  • [26] Cost-Effectiveness Analysis Between Sacral Neuromodulation and OnabotulinumtoxinA for the Treatment of Refractory Overactive Bladder in Women: A Systematic Review
    Gerjevic, Kristen A.
    Ahmad, Sophia
    Strohbehn, Kris
    Riblet, Natalie
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2021, 76 (11) : 667 - 668
  • [27] COST-EFFECTIVENESS OF SACRAL NEUROMODULATION VERSUS BOTULINUM TOXIN A FOR REFRACTORY IDIOPATHIC OAB-WET IN THE ITALIAN PERSPECTIVE
    Vottero, Mario
    Bertapelle, Paola
    Spinelli, Michele
    Delpopolo, Giulio
    Mencarini, Marco
    Giannantoni, Antonella
    Ostardo, Edoardo
    NEUROUROLOGY AND URODYNAMICS, 2013, 32 : S14 - S15
  • [28] Sacral neuromodulation and botulinum toxin-type A in overactive bladder: Timing of combination
    Bertapelle, M. P.
    Delta Ore, M. C.
    Bodo, G.
    Carone, R.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 247 - 247
  • [29] A MARKOV MODEL COMPARING SACRAL NEUROMODULATION AND BOTULINUM TOXIN-A FOR MEDICARE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER REFRACTORY TO CONSERVATIVE CARE
    Ganz, M.
    Clemens, J. Q.
    Anger, J.
    Denevich, S.
    Shah, D.
    Carlson, A.
    Wittek, M. R.
    Pashos, C.
    VALUE IN HEALTH, 2011, 14 (03) : A76 - A77
  • [30] THE REFRACTORY OVERACTIVE BLADDER: SACRAL NEUROMODULATION VS. BOTULINUM TOXIN ASSESSMENT (ROSETTA)
    Amundsen, C.
    Richter, H.
    Menefee, S.
    Komesu, Y.
    Arya, L.
    Gregory, W. T.
    Myers, D.
    Zyczynski, H.
    Vasavada, S.
    Nolen, T.
    Wallace, D.
    Meikle, S.
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 : S23 - S24
12345